Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human papillomavirus genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
Damgaard RK, Jenkins D, Stoler MH, de Koning M, van de Sandt M, Lycke KD, Kahlert J, Gravitt PE, Quint WGV, Steiniche T, Petersen LK, Hammer A. Damgaard RK, et al. Among authors: gravitt pe. Am J Obstet Gynecol. 2024 Jun;230(6):655.e1-655.e10. doi: 10.1016/j.ajog.2024.01.029. Epub 2024 Feb 7. Am J Obstet Gynecol. 2024. PMID: 38336125 Free article.
Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico.
Rudolph SE, Lorincz A, Wheeler CM, Gravitt P, Lazcano-Ponce E, Torres-Ibarra L, León-Maldonado L, Ramírez P, Rivera B, Hernández R, Franco EL, Cuzick J, Méndez-Hernández P, Salmerón J; FRIDA Study Group. Rudolph SE, et al. BMC Infect Dis. 2016 Sep 1;16(1):461. doi: 10.1186/s12879-016-1782-x. BMC Infect Dis. 2016. PMID: 27585544 Free PMC article.
Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer.
Halec G, Alemany L, Lloveras B, Schmitt M, Alejo M, Bosch FX, Tous S, Klaustermeier JE, Guimerà N, Grabe N, Lahrmann B, Gissmann L, Quint W, Bosch FX, de Sanjose S, Pawlita M; Retrospective International Survey and HPV Time Trends Study Group; Retrospective International Survey and HPV Time Trends Study Group. Halec G, et al. J Pathol. 2014 Dec;234(4):441-51. doi: 10.1002/path.4405. Epub 2014 Sep 12. J Pathol. 2014. PMID: 25043390
Catalyzing Change: Assessing Inner Setting Context of Cervical Cancer Prevention Efforts in Loreto, Peru, Prior to Transition from VIA to HPV Screen-and-Treat.
Nussbaum L, Brown J, Meza-Sánchez G, Soto S, Jurczuk M, Vásquez JV, Grandez HD, Jara LEC, Liñán RL, Gravitt PE, Paz-Soldán VA. Nussbaum L, et al. Among authors: gravitt pe. Res Sq [Preprint]. 2024 Sep 27:rs.3.rs-4992569. doi: 10.21203/rs.3.rs-4992569/v1. Res Sq. 2024. PMID: 39399675 Free PMC article. Preprint.
Challenges associated with follow-up care after implementation of an HPV screen-and-treat program with ablative therapy for cervical cancer prevention.
Morse RM, Brown J, Ríos López EJ, Prieto BA, Kohler-Smith A, Gonzales Díaz K, Figueredo Escudero M, Lenin Del Cuadro D, Vásquez Del Aguila G, Daza Grandez H, Meza-Sánchez G, Tracy JK, Gravitt PE, Paz-Soldan VA; Proyecto Precancer Study Group. Morse RM, et al. Among authors: gravitt pe. BMC Public Health. 2024 Aug 6;24(1):2121. doi: 10.1186/s12889-024-19436-3. BMC Public Health. 2024. PMID: 39107728 Free PMC article.
"Easy women get it": pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program.
Morse RM, Brown J, Gage JC, Prieto BA, Jurczuk M, Matos A, Vásquez Vásquez J, Reátegui RR, Meza-Sanchez G, Córdova LAD, Gravitt PE, Tracy JK, Paz-Soldan VA; Proyecto Precancer Study Group. Morse RM, et al. Among authors: gravitt pe. BMC Public Health. 2023 Dec 2;23(1):2396. doi: 10.1186/s12889-023-17324-w. BMC Public Health. 2023. PMID: 38042779 Free PMC article.
"Easy women get it": Pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program.
Morse RM, Brown J, Gage JC, Prieto BA, Jurczuk M, Matos A, Vásquez JV, Reátegui RR, Meza-Sanchez G, Córdova LAD, Gravitt PE, Tracy JK, Paz-Soldan VA. Morse RM, et al. Among authors: gravitt pe. Res Sq [Preprint]. 2023 Sep 11:rs.3.rs-3256535. doi: 10.21203/rs.3.rs-3256535/v1. Res Sq. 2023. Update in: BMC Public Health. 2023 Dec 2;23(1):2396. doi: 10.1186/s12889-023-17324-w PMID: 37790338 Free PMC article. Updated. Preprint.
Challenges associated with follow-up care after implementation of an HPV screen-and-treat program with ablative therapy for cervical cancer prevention in Iquitos, Peru: a mixed methods study.
Morse R, Brown J, Ríos López EJ, Prieto BA, Kohler-Smith A, Gonzales Díaz K, Figueredo Escudero M, Del Cuadro DL, Vásquez Del Aguila G, Daza Grandez H, Meza G, Tracy JK, Gravitt PE, Paz-Soldan VA; Proyecto Precancer Study Group. Morse R, et al. Among authors: gravitt pe. Res Sq [Preprint]. 2023 Aug 23:rs.3.rs-3210614. doi: 10.21203/rs.3.rs-3210614/v1. Res Sq. 2023. Update in: BMC Public Health. 2024 Aug 6;24(1):2121. doi: 10.1186/s12889-024-19436-3 PMID: 37674724 Free PMC article. Updated. Preprint.
207 results